EE558 Key Methodological Considerations for Developing Cost-Offset Budget Impact Models for a Range of Medical Technologies and Cost Perspectives in Ophthalmology

Abstract

Budget impact models (BIM) for pharmaceuticals often follow a consistent structure; however, this is often not the case for medical devices given varying stakeholders, types of devices, settings of use, and data availability. Several costing perspectives may be relevant which necessitates additional considerations for model parameters to inform a cost-offset structure. The objective of this research is to illustrate these key methodological considerations within ophthalmology given the range of device types and costing perspectives.